Skip to main content
Hofseth BioCare ASA logo

Hofseth BioCare ASA — Investor Relations & Filings

Ticker · HBC ISIN · NO0010598683 LEI · 5967007LIEEXZXGGEO44 OL Manufacturing
Open in API
Filings indexed 731 across all filing types
Latest filing 2025-04-11 Report Publication Anno…
Country NO Norway
Listing OL HBC

About Hofseth BioCare ASA

https://hofsethbiocare.no/

Hofseth BioCare ASA is a biotechnology company that develops and manufactures high-value nutritional ingredients from fresh Norwegian salmon off-cuts. Using a proprietary and patent-protected enzymatic hydrolysis process, the company gently extracts bioactive components, ensuring the preservation of their nutritional value. Its core products include soluble proteins (peptides), full-spectrum salmon oil, and marine calcium/collagen. These ingredients are utilized in clinically-proven finished products for both human nutrition and pet health markets, reflecting a commitment to sustainability and the full utilization of marine resources.

Recent filings

Filing Released Lang Actions
Hofseth Biocare ASA: HBC ANNUAL REPORT 2024
Report Publication Announcement Classification · 1% confidence The document is a short announcement (2481 characters) stating that the company has published its Annual Report and Sustainability Report for 2024. It explicitly says 'Please find the Annual Report and ESG Report attached', which triggers the 'Menu vs Meal' rule. Since it is an announcement of the publication of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA). FY 2024
2025-04-11 English
Hofseth Biocare ASA: CONTEMPLATING UNSECURED BOND ISSUANCE
Capital/Financing Update Classification · 1% confidence The document is titled "Hofseth Biocare ASA: CONTEMPLATING UNSECURED BOND ISSUANCE" and explicitly discusses the potential issuance of CHF-denominated unsecured bonds up to CHF 8 million, targeting investors in Switzerland and Liechtenstein. This activity directly relates to fundraising, financing activities, and capital structure changes. Based on the provided definitions, this aligns perfectly with the 'Capital/Financing Update' category (Code: CAP). The document is an announcement of intent, not a full financial report or a general regulatory filing.
2025-03-10 English
Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP
Capital/Financing Update Classification · 1% confidence The document announces a strategic partnership between Hofseth Biocare ASA (HBC) and Symrise, involving financing (a EUR 5m loan) and expansion of manufacturing capacity (tripling production at Berkåk). This clearly relates to corporate financing, capital structure changes, and significant business development. While it involves a strategic agreement, the core announcement centers on funding the expansion and distribution rights, which aligns best with the 'Capital/Financing Update' category (CAP). It is not a standard earnings release (ER), an interim report (IR), or a full annual report (10-K). Since it details a significant financing component for expansion, CAP is the most appropriate classification.
2025-02-21 English
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
Major Shareholding Notification Classification · 1% confidence The document is titled 'Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION' and details a change in shareholding by a member of the Board of Directors (Christoph Baldegger). This directly corresponds to the definition of Director's Dealing (insider trades) as per the provided categories. The filing explicitly mentions disclosure requirements under Market Abuse Regulation, confirming its nature as an insider transaction report. This matches code DIRS.
2025-02-20 English
Hofseth Biocare ASA / notification of major holdings
Major Shareholding Notification Classification · 1% confidence The document is titled "Standard form for notification of major holdings" and explicitly deals with changes in share ownership, referencing specific dates (19. Februar 2025) and resulting percentages (16.84%). This type of filing, which reports when an investor crosses a threshold of significant share ownership (usually 3%, 5%, 10%, etc.), corresponds directly to the definition of a Major Shareholding Notification. The code for this is MRQ.
2025-02-20 English
Hofseth Biocare ASA / notification of major holdings
Major Shareholding Notification Classification · 1% confidence The document text is extremely short (151 characters) and explicitly states "notification of major holdings" and directs the user to an attachment on an external site ("Please see attachment on www.newsweb.no"). This structure strongly suggests an announcement about the availability of a filing rather than the filing itself. The content relates to changes in significant share ownership, which aligns with the definition of Major Shareholding Notification (MRQ). However, given the very short length and the instruction to see an attachment, it fits the 'MENU VS MEAL' rule, suggesting it is an announcement of the report's publication. Since 'Major Shareholding Notification' (MRQ) is a specific category for the content, and 'Report Publication Announcement' (RPA) is for announcing the publication of reports in general, I must choose the most specific content-based category if the content is clearly identifiable. The title explicitly mentions 'notification of major holdings'. If this were the actual filing, it would be MRQ. Since it is just a notice pointing to the actual filing, it could be RPA or RNS. Given the specific nature of the content (major holdings), and the brevity, it is most likely a regulatory filing announcement that doesn't fit the RPA template perfectly, making RNS a strong fallback, or MRQ if we assume the notification *is* the primary document being filed, even if brief. Given the instruction to see an attachment, RPA is plausible, but MRQ is the content type. I will classify it as MRQ because the subject matter is clearly defined, and often these brief regulatory notices are filed under the content code itself, even if they are just pointers. If the content was generic, RNS would be better. Confidence is high due to the explicit title.
2025-02-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.